Tendon rupture is part of RA | Arthritis Information

Share
 

http://www.ncbi.nlm.nih.gov/pubmed/18261665?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_Discovery_RA&linkpos=2&log$=relatedarticles&logdbfrom=pubmedAnd this

 
http://www.ncbi.nlm.nih.gov/pubmed/12823854?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_Discovery_RA&linkpos=4&log$=relatedarticles&logdbfrom=pubmed
Why is this stupid thing putting a line under the link??
 
http://www.antibiotics.org/
 
http://www.adverse-drug-reaction.net/levaquin.aspx
Lynn,
 
I'm systematically going over all the meds listed on the ARC and searching them in PubMed.
 
Here's Imuran and 28 reported cases of tendon rupture in Lupus -
 
The links not working - here's the study -
 

[Spontaneous infrapatellar tendon rupture in a patient with systemic lupus erythematosus]

[Article in Danish]

Jakobsen LP, Knudsen TB, Bloch T.

Ortopaedkirurgisk afdeling M, H:S Bispebjerg Hospital.

A case is described of a 33-year old woman with systemic lupus erythematosus (SLE) in longterm treatment with corticosteroids who experienced spontaneous rupture of the left patellar tendon. A comparative study of 28 previously reported cases of SLE patients with spontaneous tendon rupture in weight bearing joints is performed. It is suggested that renal disease may be an etiological factor for spontaneous tendon rupture in patients with systemic lupus erythematosus.

PMID: 11014141 [PubMed - indexed for MEDLINE]

 
Pip
Pip!2008-07-09 16:02:44Anakinra
 
: Z Rheumatol. 2003 Dec;62(6):566-9. < =1.2> Links

[Phlegmon of the forearm due to therapy with Anakinra (interleukin-1 receptor-antagonist)]

[Article in German]

Gaulke R.

Evangelische Stiftung Volmarstein Klinik II: Rheumaorthopädie- Endoprothetik, Sektion Handchirurgie, Lothar-Gau-Str. 11, 58300 Wetter-Volmarstein, Germany.

INTRODUCTION: Biological modifiers (BM) are very effective in a high percentage of patients with rheumatoid arthritis being resistant to disease modifying antirheumatic drugs (DMARD). In the beginning, the therapy with the BMs was thought to be of low risk. However, due to the increase of application, a few lethal septical complications have been reported. CASE REPORT: A 38 year old male with rheumatoid arthritis and insulin deficiency diabetes mellitus achieved remission under the therapy with Anakinra within three days. Due to a spontaneous disrupture of the finger extensor tendons operative revision was performed. A phlegmon from the dorsum of the hand to the cubita was found five months after resection of a septical cubital bursa. CONCLUSION: The very effective suppression of the immune system by the BMs should not lead to noncritical therapy in patients with history of infections of bone, joints and soft tissue, because inactive organism may start growing and lead to undetected lethal sepsis.

PMID: 14685719 [PubMed - indexed for MEDLINE

Cytoxan - Cyclophosphamide
 
< id=Uid = value=14579169 name=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.uid sid="1">1:
Related Articles, < =1.2> Links
de La Red G, Mejía JC, Cervera R, Lladó A, Mensa J, Font J.
Bilateral Achilles tendinitis with spontaneous rupture induced by levofloxacin in a patient with systemic sclerosis.
Clin Rheumatol. 2003 Oct;22(4-5):367-8. No abstract available.
PMID: 14579169 [PubMed - indexed for MEDLINE]
< =1.2>
Copyright ArthritisInsight.com